• LAST PRICE
    9.6100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    9.3700/ 1
  • Ask / Lots
    10.3600/ 4
  • Open / Previous Close
    0.0000 / 9.6100
  • Day Range
    ---
  • 52 Week Range
    Low 4.2150
    High 10.8300
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 9.33
TimeVolumeSIGA
09:32 ET55939.29
09:34 ET5439.36
09:36 ET14849.34
09:39 ET15009.27
09:41 ET23539.305
09:45 ET28009.255
09:48 ET42159.28
09:50 ET1009.2598
09:52 ET6629.29
09:54 ET2269.3
09:56 ET8779.26
09:57 ET9789.22
09:59 ET11149.195
10:01 ET110109.125
10:03 ET1969.14
10:06 ET9009.1531
10:08 ET19059.15
10:14 ET4709.14
10:15 ET2109.155
10:17 ET1009.165
10:19 ET3009.13
10:28 ET7009.15
10:32 ET4309.149
10:33 ET1009.15
10:35 ET1009.15
10:37 ET2319.1409
10:39 ET3169.17
10:42 ET2009.195
10:44 ET5749.21
10:48 ET13659.23
10:50 ET4169.215
10:53 ET56259.1999
10:57 ET2009.23
11:00 ET2009.26
11:02 ET11799.26
11:04 ET78779.285
11:06 ET3169.29
11:08 ET1009.3
11:09 ET1009.27
11:11 ET4109.25
11:15 ET1009.27
11:18 ET2939.265
11:20 ET4009.315
11:24 ET3009.29
11:26 ET1009.29
11:27 ET5589.3
11:29 ET2259.3
11:31 ET6499.305
11:33 ET1009.31
11:42 ET10529.3
11:44 ET2009.315
11:45 ET1429.32
11:51 ET4159.35
11:54 ET22009.365
11:56 ET8009.33
12:02 ET80259.33
12:07 ET9579.33
12:09 ET13009.3599
12:16 ET1009.355
12:18 ET2509.355
12:20 ET8369.37
12:23 ET1009.36
12:25 ET16019.37
12:30 ET1009.36
12:32 ET11639.36
12:34 ET6509.365
12:36 ET6809.39
12:38 ET5559.3888
12:41 ET24009.34
12:45 ET2009.355
12:48 ET4009.38
12:50 ET3119.4
12:52 ET11459.39
12:54 ET3809.41
12:59 ET2009.3901
01:01 ET5009.41
01:03 ET11649.4
01:06 ET2009.4
01:08 ET2009.4
01:10 ET3009.4
01:12 ET2359.3976
01:14 ET10029.4
01:15 ET27799.38
01:17 ET3659.39
01:21 ET1009.405
01:28 ET10009.41
01:30 ET5129.4
01:32 ET27499.4
01:33 ET4009.4
01:42 ET3009.4
01:44 ET1009.4
01:46 ET1759.4
01:48 ET2009.3998
01:51 ET4009.39
01:53 ET8009.38
01:57 ET4789.38
02:04 ET26109.3999
02:15 ET33239.39
02:18 ET1009.385
02:22 ET1009.385
02:26 ET2009.39
02:27 ET26839.395
02:31 ET6009.39
02:33 ET14009.41
02:36 ET7569.3924
02:38 ET4439.4
02:40 ET41129.41
02:42 ET7009.4
02:44 ET4009.39
02:45 ET2249.4
02:47 ET1009.39
02:49 ET1139.4
02:51 ET5009.4
02:56 ET6009.41
03:02 ET14819.41
03:03 ET30009.41
03:05 ET15579.43
03:07 ET18629.44
03:09 ET11189.46
03:12 ET13269.46
03:14 ET1009.45
03:16 ET24889.45
03:18 ET17509.455
03:20 ET67509.47
03:21 ET24279.5174
03:23 ET5579.53
03:25 ET57639.54
03:27 ET13729.56
03:30 ET9009.57
03:32 ET10479.58
03:34 ET82299.62
03:36 ET130679.67
03:38 ET60509.66
03:39 ET27599.66
03:41 ET1009.66
03:43 ET15199.65
03:45 ET38569.665
03:48 ET29649.66
03:50 ET14009.64
03:52 ET41279.62
03:54 ET67869.64
03:56 ET41439.61
03:57 ET27239.605
03:59 ET571509.61
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSIGA
SIGA Technologies Inc
640.8M
8.8x
-28.78%
United StatesESPR
Esperion Therapeutics Inc
496.4M
-2.4x
---
United StatesHROW
Harrow Inc
889.9M
-27.8x
---
United StatesBVNRY
Bavarian Nordic A/S
2.1B
14.5x
---
United StatesXERS
Xeris Biopharma Holdings Inc
363.2M
-5.3x
---
United StatesEOLS
Evolus Inc
748.2M
-11.8x
---
As of 2024-07-23

Company Information

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The Company's lead product is TPOXX, also known as tecovirimat and ST-246, an orally administered and intravenous (IV) formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the United States maintains a supply of TPOXX under Project BioShield. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox. It uses third parties known as contract manufacturing organizations to procure commercial raw materials and supplies, and to manufacture TPOXX.

Contact Information

Headquarters
31 East 62Nd StreetNEW YORK, NY, United States 10065
Phone
212-672-9100
Fax
212-697-3130

Executives

Chief Executive Officer, Director
Diem Nguyen
Chief Financial Officer, Executive Vice President, Corporate Secretary
Daniel Luckshire
Executive Vice President, Chief Scientific Officer
Dennis Hruby
Executive Vice President, Chief Medical Officer, Director
Jay Varma
General Counsel
Lawrence Miller

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$640.8M
Revenue (TTM)
$157.0M
Shares Outstanding
71.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.95
EPS
$1.10
Book Value
$2.77
P/E Ratio
8.8x
Price/Sales (TTM)
4.1
Price/Cash Flow (TTM)
8.0x
Operating Margin
61.78%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.